Literature DB >> 27538458

The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present).

Patrycja Kleczkowska1, Agnieszka Kowalczyk, Anna Lesniak, Magdalena Bujalska-Zadrozny.   

Abstract

The search for a miracle drug that would help to alleviate multiple ailments, dates back many thousands of years before our era and continues until today. Various techniques have been used to obtain a formulation, that would give the desired therapeutic effect. The most popular approach includes drug coctails and multicomponent drugs. Polytherapy is widely accapted as an effective tool for the treatment of several diseases, however it is often faced with important drawbacks that may sometimes result in fatal adverse effects associated with unpredictable drug interactions. Conversly, hybrid compounds were found to be an attractive way to counterbalance the unwanted side effects derived from the administration of individual drug components. Futhermore, they can serve as effective and improved remedies for patients suffering from several diseases simultaneously, as different receptorrelated pharmacophores are used as structural components. This review covers patent literature from 1980 till now that highlights the progress that has been made in the discovery of hybrid compounds potentially useful in the treatment on various disorders, including pain states, neurodegenerative or infectious diseases. Additionally, this review was further enriched with findings from original research papers. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer; Cardiovascular diseases; Hybrid drugs; Infectus diseases; Multifunctional ligands; Neurodegeneration; Pain

Mesh:

Substances:

Year:  2017        PMID: 27538458     DOI: 10.2174/1568026616666160818152257

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  1 in total

1.  Endomorphin-2- and Neurotensin- Based Chimeric Peptide Attenuates Airway Inflammation in Mouse Model of Nonallergic Asthma.

Authors:  Ewelina Russjan; Kryspin Andrzejewski; Dorota Sulejczak; Patrycja Kleczkowska; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.